Results 151 to 160 of about 11,689 (208)

Preexisting IgG forms immune complexes and links local thermal reactogenicity with immunogenicity in influenza vaccination

Hirsiger JR, Scarascia S, Recher M, Bantug G, Berger CT.   +4 more
europepmc   +1 more source

Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years. [PDF]

Hum Vaccin Immunother
Kostanyan L, Wu I, Sinkiewicz M, Cardona J, Johnson K, Das R.   +5 more
europepmc   +1 more source

Advancing Needle-Free Jet Injectors for Global Vaccine Delivery. [PDF]

Pharmaceutics
Ikechukwu P, Agu R.
europepmc   +1 more source

Systems vaccinology analysis of saRNA immunization identifies an acute innate immune signature correlated with adaptive immunity. [PDF]

Mol Ther Adv
Elliott T, Wang Z, Bonduelle O, Evans A, Day S, McFarlane LR, de Bernard S, Alves K, Nourikyan J, Wokam M, Pollock K, Cheeseman HM, Combadiere B, Shattock RJ, Tregoning JS.   +14 more
europepmc   +1 more source

Reactogenicity of hexavalent vaccines modelled in Swedish birth cohorts

Acta Paediatrica
George Marina, Lundholm Lotta, Silfverdal Sven Arne   +2 more
openaire   +3 more sources

Tiny packages, big potential: bacterial membrane vesicles in vaccinology. [PDF]

Microb Cell Fact
Varol A, Aydın Ş, Adıgüzel A, Özdemir S.   +3 more
europepmc   +1 more source

A comprehensive analysis of the use of nucleoside analogues in RNA therapeutics. [PDF]

J Transl Med
Kukushkina-Zvezdova AA, Zherebtsova AA, Telegina DV, Skvortsov IA, Ivanov RA, Reshetnikov VV.   +5 more
europepmc   +1 more source

Safety and Immunogenicity of 1 or 2 Additional Doses of the Adjuvanted Recombinant Zoster Vaccine Administered 5-6 Years After Primary Vaccination in Adults ≥50 Years. [PDF]

Open Forum Infect Dis
Leon R, Diez-Domingo J, Andrews C, Arns da Cunha C, Choo EJ, Hui DSC, Cunningham AL, Eto T, Icardi G, McNeil SA, Põder A, Kosina P, Rombo L, Schwarz TF, Tinoco JC, Yu CJ, Wang J, Soni J, Tsang M, Strezova A, Salaun B, Mwakingwe-Omari A.   +21 more
europepmc   +1 more source

A modular vaccine platform merging the rapid development of genetic vaccines with the immunogenicity of virus-like particles. [PDF]

Clin Transl Med
Sander AF, Fougeroux C.
europepmc   +1 more source

Engineering a safe and potent LNP-mRNA delivery system by leveraging the dual activities of α-tocopherol. [PDF]

Int J Pharm X
Wang H, Kang Z, Wang X, Pan Z, Sun Y, Li Y, Li X, Shao S, Zheng X, Han Z, Ren J.   +10 more
europepmc   +1 more source